Literature DB >> 27189203

Clinical and gender differences in heart transplant recipients in the NEW HEART study.

Kathleen T Hickey1, Lynn V Doering2, Belinda Chen2, Erik V Carter3, Robert R Sciacca1, David Pickham4, Carmen Castillo1, Nicole R Hauser5, Barbara J Drew3.   

Abstract

BACKGROUND: Little attention has focused on gender differences in cardiac comorbidities and outcomes in patients undergoing orthotropic heart transplant.
OBJECTIVE: The objective of this study was to investigate gender differences at baseline and during follow-up among heart transplant patients.
METHODS: An observational cohort within the NEW HEART study was evaluated to determine gender differences in relation to age, coexisting cardiac comorbidities, and outcomes. Differences were assessed by t-test, Fisher's exact test, and logistic regression analysis.
RESULTS: Male transplant recipients ( n = 238) were significantly older than female recipients ( n = 92), with a greater percentage over 60 years of age (45% vs. 24%, p = 0.0006). Males were more likely to have hypertension (63% vs. 49%, p = 0.034), dyslipidemia (62% vs. 45%, p = 0.006), a history of smoking (52% vs. 35%, p = 0.009), and diabetes (42% vs. 21%, p = 0.0002). Analysis of endomyocardial biopsies obtained during the 1-year follow-up period demonstrated that women averaged more episodes of acute rejection than men (3.9 vs. 3.0, p = 0.009). While most episodes of rejection were mild, women were more likely than men to have episodes of moderate or severe rejection (14% vs. 5%, p = 0.012) and to be hospitalized for acute rejection (15% vs. 6%, p = 0.013). There were no significant differences in mortality.
CONCLUSIONS: Men were more likely than women to be older and to have diabetes, dyslipidemia, hypertension, and a history of smoking. Women were more likely to experience moderate or severe allograft rejection and to be hospitalized for acute rejection. Future investigation of the reasons for these gender differences is warranted and may improve clinical care of women undergoing cardiac transplantation.

Entities:  

Keywords:  ECG monitoring; gender; heart transplant

Mesh:

Year:  2016        PMID: 27189203      PMCID: PMC5526208          DOI: 10.1177/1474515116651178

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  25 in total

1.  The long-term outcome of treated sensitized patients who undergo heart transplantation.

Authors:  Jon A Kobashigawa; Jignesh K Patel; Michelle M Kittleson; Matt A Kawano; Krista K Kiyosaki; Stephanie N Davis; Jaime D Moriguchi; Elaine F Reed; Abbas A Ardehali
Journal:  Clin Transplant       Date:  2010-10-25       Impact factor: 2.863

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

3.  Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database.

Authors:  Kismet Rasmusson; Kim Brunisholz; Deborah Budge; Benjamin D Horne; Rami Alharethi; Jan Folsom; Jenny J Connolly; Josef Stehlik; Abdallah Kfoury
Journal:  J Heart Lung Transplant       Date:  2012-02       Impact factor: 10.247

4.  Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

Authors:  H Haddad; D Isaac; J F Legare; P Pflugfelder; P Hendry; M Chan; B Cantin; N Giannetti; S Zieroth; M White; W Warnica; K Doucette; V Rao; A Dipchand; M Cantarovich; W Kostuk; R Cecere; E Charbonneau; H Ross; N Poirier
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

5.  Sixth INTERMACS annual report: a 10,000-patient database.

Authors:  James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2014-04-21       Impact factor: 10.247

6.  Does the UNOS heart transplant allocation system favor men over women?

Authors:  Eileen M Hsich; Randall C Starling; Eugene H Blackstone; Tajinder P Singh; James B Young; Eiran Z Gorodeski; David O Taylor; Jesse D Schold
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

7.  U.S. donor heart allocation bias for men over women?: A closer look.

Authors:  Jon A Kobashigawa
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

8.  Comparison of heart transplantation patients with ischemic and idiopathic dilated cardiomyopathy.

Authors:  H Gungor; E Oguz; M F Ayik; S Ertugay; C Engin; T Yagdi; S Nalbantgil; M Zoghi; M Ozbaran
Journal:  Transplant Proc       Date:  2011-12       Impact factor: 1.066

Review 9.  Representation of women in randomized clinical trials of cardiovascular disease prevention.

Authors:  Chiara Melloni; Jeffrey S Berger; Tracy Y Wang; Funda Gunes; Amanda Stebbins; Karen S Pieper; Rowena J Dolor; Pamela S Douglas; Daniel B Mark; L Kristin Newby
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-02-16

Review 10.  The effectiveness of non-pharmacological interventions in improving psychological outcomes for heart transplant recipients: a systematic review.

Authors:  Aaron Conway; Verena Schadewaldt; Robyn Clark; Chantal Ski; David R Thompson; Kathryn Kynoch; Lynn Doering
Journal:  Eur J Cardiovasc Nurs       Date:  2014-01-06       Impact factor: 3.908

View more
  6 in total

Review 1.  Sex-Related Differences in Outcomes of Thoracic Organ Transplantation and Mechanical Circulatory Support.

Authors:  Daoud Daoud; Faisal H Cheema; Jeffrey A Morgan; Gabriel Loor
Journal:  Tex Heart Inst J       Date:  2018-08-01

2.  Diltiazem as a cyclosporine A-sparing agent in heart transplantation: Benefits beyond dose reduction.

Authors:  Emyal Alyaydin; Holger Reinecke; Izabela Tuleta; Juergen R Sindermann
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

3.  Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

Authors:  María Dolores García-Cosío; Francisco González-Vilchez; Raquel López-Vilella; Eduardo Barge-Caballero; Manuel Gómez Bueno; Manuel Martínez-Selles; Jose María Arizón; Diego Rangel Sousa; José González-Costello; Sonia Mirabet; Félix Pérez-Villa; Beatriz Díaz Molina; Gregorio Rábago; Ana Portolés Ocampo; Luis de la Fuente Galán; Iris Garrido; Juan F Delgado
Journal:  Front Cardiovasc Med       Date:  2021-02-25

Review 4.  The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease.

Authors:  Christine Pacheco; Kerri-Anne Mullen; Thais Coutinho; Shahin Jaffer; Monica Parry; Harriette G C Van Spall; Marie-Annick Clavel; Jodi D Edwards; Tara Sedlak; Colleen M Norris; Abida Dhukai; Jasmine Grewal; Sharon L Mulvagh
Journal:  CJC Open       Date:  2021-11-23

Review 5.  Special Considerations in the Care of Women With Advanced Heart Failure.

Authors:  Imo A Ebong; Ersilia M DeFilippis; Eman A Hamad; Eileen M Hsich; Varinder K Randhawa; Filio Billia; Mahwash Kassi; Anju Bhardwaj; Mirnela Byku; Mrudala R Munagala; Roopa A Rao; Amy E Hackmann; Claudia G Gidea; Teresa DeMarco; Shelley A Hall
Journal:  Front Cardiovasc Med       Date:  2022-07-11

6.  Difference in absolute lymphocyte count among male and female heart transplant recipients.

Authors:  Whitney A Perry; Jennifer K Chow; David R Snydman
Journal:  Clin Transplant       Date:  2021-07-19       Impact factor: 3.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.